Edoxaban Impurity 132 | CAS 1392745-22-0 - Request Quote
Edoxaban Impurity 132
| SZ CAT No: | SZ-E041164 |
| CAS No | 1392745-22-0 |
| Mol.F. | C14H25NO5 |
| Mol.Wt. | 287.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Edoxaban Impurity 132 is chemically ethyl (1S,3R,4S)-3-((tert-butoxycarbonyl)amino)-4-hydroxycyclohexane-1-carboxylate. Edoxaban Impurity 132 is supplied with detailed characterization data compliant with regulatory guideline. Edoxaban Impurity 132 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Edoxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1392745-22-0
Purchase 1392745-22-0
Order 1392745-22-0
Enquire 1392745-22-0
price of 1392745-22-0
1392745-22-0 Supplier
1392745-22-0 Manufacturer
1392745-22-0 Exporter
buy high quality Edoxaban Impurity 132
Purchase Edoxaban Impurity 132
Edoxaban Impurity 132 suppliers
Edoxaban Impurity 132 manufacturers
Edoxaban Impurity 132 price
Order Edoxaban Impurity 132
Enquire Edoxaban Impurity 132
Edoxaban Impurity 132 cost
Edoxaban Impurity 132 Supplier
Edoxaban Impurity 132 Distributor
Edoxaban Impurity 132 for Method Validation
Edoxaban Reference Standard
Edoxaban Impurity 132 for ANDA Filing
Edoxaban Impurity 132 for Forced Degradation Studies
Edoxaban Impurity 132 Identification Standards
Edoxaban Impurity 132 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.